FERM domain containing 8 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored FRMD8P1 profile across patient tissues and cancer cell-line models. FRMD8P1 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, FRMD8P1 is differentially expressed in 6, with the highest sampling consensus in HNSC. Additionally, FRMD8P1 RNA expression shows 9,401 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight SKCM, HNSC, and THYM as cancer lineages where FRMD8P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for FRMD8P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes FRMD8P1 survival associations across molecular data types. FRMD8P1 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible FRMD8P1 RNA expression–survival associations across cancer types. High FRMD8P1 expression shows unfavorable associations in ACC, OV and READ, but favorable associations in SKCM, CESC and STAD. The SKCM Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for FRMD8P1 RNA expression.
This table summarizes FRMD8P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for FRMD8P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. FRMD8P1 shows higher tumor expression in HNSC, COAD, LUSC, UCEC, STAD and LUAD. The HNSC box plot shows higher FRMD8P1 RNA expression in tumor versus normal tissue (log2 FC = +0.067, t-test p < 0.001).
This table shows molecular features associated with FRMD8P1 in patient tissues and cancer cell lines. In patient samples, FRMD8P1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
